1. Slide 1 of 13 Rob Packard, President www.MedicalDeviceAcademy.com [email protected] FDA Enforcement Inspections, Trends: A Q&A Session with a former FDA Investigator…

By: Mukesh Kumar Jaiswal Falsification of data in proposing, designing, performing, recording, supervising or reviewing research, or in reporting research results. Falsification…

Clinical Trials in Russia FROM A CENTRAL LAB PERSPECTIVE Tomasz Anyszek, Synevo Central Labs Director Michal Dysko, Head of Business Development Business Review Webinars…

GxP and cGxP in Bio/Pharmaceutical Industry Prof. Dr. Basavaraj K. Nanjwade M. Pharm., Ph. D Department of Pharmaceutics KLE University College of Pharmacy BELGAUM – 590010,…

1. FDAMAP Making Regulations Easy…. www.FDAMap.com Email: [email protected] 410-501-5777 20203 Goshen Rd, Suite 261 Gaithersburg, MD 20879 Simple Ways to Prepare For an FDA…

Slide 1The FDA Inspection Process February 17, 2010 Slide 2 Topics n Discuss the FDA inspection process n Describe the type of outcomes n Review material that is reviewed…

Slide 1GxP and cGxP in Bio/Pharmaceutical Industry Prof. Dr. Basavaraj K. Nanjwade M. Pharm., Ph. D Department of Pharmaceutics KLE University College of Pharmacy BELGAUM…

Slide 1 Proposed Rule Accreditation of Third-Party Auditors/Certification Bodies http://www.fda.gov/fsma Slide 2 Key Principles A credible third-party program will: –Allow…

Slide 1 Meeting Regulatory Requirements for Electronic Signatures Presentation by Daniel Worden at the Validation Institute LIMS Electronic Signature/Validation Conference…

Slide 1 Fraud & Misconduct at Investigator Sites Paul Below Medical Affairs - 3M Pharmaceuticals Presented to the Great Plains Chapter ACRP March 27, 2003 Slide 2 The…